Supernus Pharmaceuticals SUPN Balance Sheet (2011-2026)

NASDAQ SUPN
$43.97 -0.63 (-1.41%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Supernus Pharmaceuticals Quarterly Balance Sheet

Periods 62 quarters
Latest Jun 2026

Supernus Pharmaceuticals reported total assets of $1428.11M and total liabilities of $396.88M for the quarter ended Jun 2026, up 3.3% year over year. This balance sheet covers 62 quarters of results from Mar 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
215.28M203.43M115.72M173.43M111.49M93.12M58.44M24.71M94.98M75.05M63.40M52.09M31.67M69.33M115.85M144.71M151.37M128.45M184.87M179.95M
Short-term InvestmentsInvestments (Current)
228.57M136.25M196.49M187.36M280.30M368.21M170.13M126.95M105.20M179.82M234.34M295.10M371.54M384.28M347.74M377.88M129.79M180.22M199.37M192.11M
Cash & Current Investments
443.85M339.68M312.20M360.79M391.79M461.33M228.57M151.66M200.19M254.87M297.74M347.19M403.21M453.61M463.59M522.60M281.16M308.67M384.24M372.07M
Receivables - NetNet Receivables
133.68M148.93M145.15M158.06M164.09M165.50M143.57M136.56M141.76M144.16M147.73M152.49M145.41M142.08M145.64M140.83M171.25M187.80M182.18M211.66M
Receivables - OtherOther Receivables
4.00M5.40M6.30M1.80M1.90M4.30M
Receivables
133.68M148.93M145.15M158.06M164.09M165.50M143.57M136.56M141.76M144.16M147.73M152.49M145.41M146.08M145.64M146.23M177.55M189.60M184.08M215.96M
Raw Materials
9.71M7.33M9.24M7.46M11.01M24.82M22.92M28.16M21.56M16.27M18.80M15.90M11.57M11.13M8.66M8.42M56.99M31.83M31.47M22.96M
Work In Process
37.91M45.71M46.22M36.86M25.46M31.71M33.98M23.59M26.97M31.21M23.25M23.59M28.10M26.73M18.69M15.65M33.41M29.44M36.05M27.16M
Finished Goods
12.54M32.92M33.34M40.54M46.69M35.01M34.26M38.81M34.96M29.92M33.03M28.67M24.31M16.44M22.07M19.95M16.70M21.12M19.54M33.80M
Inventory
60.16M85.96M88.80M84.86M83.17M91.54M91.15M90.56M83.48M77.41M75.08M68.16M63.98M54.29M49.42M44.02M79.40M82.39M87.06M83.92M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
30.69M27.02M22.37M21.41M24.85M15.78M16.30M44.77M23.93M16.68M23.77M23.17M27.40M36.09M28.93M31.42M62.08M65.33M78.09M55.85M
Current Assets
668.38M601.59M568.52M625.12M663.89M734.15M883.34M423.54M449.36M493.11M544.32M591.00M640.00M686.07M687.58M738.87M593.89M644.18M731.58M723.50M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
16.47M16.95M17.21M16.32M15.87M15.17M14.61M14.19M13.69M13.53M12.97M12.27M11.88M11.54M11.34M11.07M10.63M10.53M10.04M10.20M
Long-Term Investments
405.48M119.17M125.34M147.37M131.94M93.90M54.16M37.48M25.12M16.62M11.66M
Goodwill
77.96M117.52M115.41M115.41M117.38M117.02M117.02M117.02M117.02M117.02M117.02M117.02M117.02M117.02M117.02M117.02M119.08M124.88M120.67M119.43M
Intangibles
346.62M784.69M764.05M743.40M722.76M702.46M682.50M662.39M641.15M599.89M579.75M559.64M540.16M521.91M502.13M481.31M623.48M569.46M549.71M469.46M
Goodwill & Intangibles
424.58M902.21M879.46M858.82M840.14M819.48M799.52M779.41M758.17M716.91M696.77M676.66M657.17M638.93M619.14M598.33M742.56M694.34M670.38M588.89M
Long-Term Deferred Tax
6.18M8.79M38.35M30.82M49.06M
Other Non-Current Assets
40.13M49.23M48.99M47.34M41.29M39.81M403.80M38.49M38.82M38.37M35.89M31.53M62.43M63.80M56.45M55.02M
Non-Current Assets
886.66M1,087.56M1,071.00M1,069.85M1,029.24M968.36M908.47M869.56M835.80M784.56M759.77M724.83M702.70M682.00M659.71M643.54M825.86M808.47M769.14M704.61M
Assets
1,555.04M1,689.15M1,639.52M1,694.97M1,693.13M1,702.51M1,791.81M1,293.10M1,285.16M1,277.67M1,304.09M1,315.83M1,342.70M1,368.07M1,347.29M1,382.40M1,419.75M1,452.65M1,500.72M1,428.11M
Liabilities
Current Liabilities
Accounts Payables
72.29M117.68M89.43M133.00M110.30M96.34M95.34M83.04M78.47M79.57M86.40M82.61M75.80M76.35M76.89M77.74M108.61M107.80M101.24M108.46M
Notes Payables
401.97M402.50M
Payables
72.29M117.68M89.43M133.00M110.30M498.31M497.85M83.04M78.47M79.57M86.40M82.61M75.80M76.35M76.89M77.74M108.61M107.80M101.24M108.46M
Accumulated Expenses
72.29M117.68M89.43M133.00M110.30M96.34M95.34M83.04M78.47M79.57M86.40M82.61M75.80M76.35M76.89M77.74M108.61M107.80M101.24M108.46M
Other Accumulated Expenses
132.05M132.72M140.18M145.76M158.47M151.66M147.85M148.83M162.47M154.27M167.23M175.12M169.12M168.71M170.13M180.92M184.46M161.10M189.72M198.84M
Short term Debt
400.91M401.44M78.36M
Current Leases
Current Taxes
Current Deferred Revenue
Total Current Liabilities
234.71M315.38M284.56M735.54M725.99M687.96M731.54M252.59M287.53M290.20M314.55M308.66M291.51M292.40M281.77M286.36M330.63M338.17M373.93M347.38M
Non-Current Liabilities
Capital Leases
Non-Current Debt
379.25M
Convertible Debt
374.79M379.25M400.38M
Non-Current Deffered Revenue
Pension
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
34.15M85.36M62.84M59.31M58.16M49.81M49.67M44.30M35.22M24.96M19.50M11.44M7.36M4.96M0.98M
Operating Leases
37.26M41.30M39.89M37.08M36.03M36.00M36.51M34.18M33.84M33.20M32.99M30.29M28.93M27.38M26.37M24.38M31.42M30.36M30.27M29.43M
Other Non-Current Liabilities
69.05M80.48M56.14M56.88M57.37M54.97M53.32M54.11M53.65M53.45M52.35M48.00M46.98M47.34M30.00M7.76M11.45M31.26M19.52M19.87M
Total Non-Current Liabilities
675.52M792.82M754.93M796.65M782.96M761.34M826.34M319.08M319.31M302.71M322.57M310.38M288.57M285.00M286.58M310.74M358.64M359.68M404.40M377.01M
Total Liabilities
744.57M873.30M811.07M853.54M840.33M816.30M879.66M373.19M372.97M356.16M374.92M358.38M335.55M332.34M316.58M318.50M370.09M390.93M423.92M396.88M
Shareholder's Equity
Total Debt
379.25M400.91M401.44M401.97M480.86M
Common Equity
810.47M815.85M828.45M841.43M852.80M886.20M912.15M919.91M912.19M921.52M929.17M957.45M1,007.15M1,035.73M1,030.70M1,063.90M1,049.67M1,061.71M1,076.81M1,031.23M
Liabilities and Shareholders Equity
1,555.04M1,689.15M1,639.52M1,694.97M1,693.13M1,702.51M1,791.81M1,293.10M1,285.16M1,277.67M1,304.09M1,315.83M1,342.70M1,368.07M1,347.29M1,382.40M1,419.75M1,452.65M1,500.72M1,428.11M
Retained Earnings
377.48M379.92M446.15M454.01M455.76M481.25M498.19M497.36M481.39M482.56M482.69M502.60M541.10M556.43M544.60M567.10M521.98M517.88M515.58M457.21M
Preferred Shares

Supernus Pharmaceuticals Balance Sheet API

Pull Supernus Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SUPN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY